Clinical Trial Update: Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating retigabine for partial-onset refractory seizures in epilepsy has completed, with efficacy and safety results posted in November 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Retigabine (ezogabine) (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Seizures | Phase 3 | Status: COMPLETED | Results posted: 2011-11-07